Share-based Payment Arrangement, Expense of Pacira BioSciences, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pacira BioSciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $13,499,000, a 10% increase year-over-year.
  • Pacira BioSciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $57,502,000, a 12% increase year-over-year.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $57,502,000, a 12% increase from 2024.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $51,171,000, a 6.8% increase from 2023.
  • Pacira BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $47,895,000, a 0.41% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Pacira BioSciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $57,502,000 $13,499,000 +$1,233,000 +10% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $56,269,000 $13,978,000 +$748,000 +5.7% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $55,521,000 $15,472,000 +$2,948,000 +24% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $52,573,000 $14,553,000 +$1,402,000 +11% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $51,171,000 $12,266,000 -$154,000 -1.2% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $51,325,000 $13,230,000 +$700,000 +5.6% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $50,625,000 $12,524,000 +$1,569,000 +14% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $49,056,000 $13,151,000 +$1,161,000 +9.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $47,895,000 $12,420,000 -$257,000 -2% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $48,152,000 $12,530,000 -$152,000 -1.2% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $48,304,000 $10,955,000 -$589,000 -5.1% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024 2024 Q2
Q1 2023 $48,893,000 $11,990,000 +$801,000 +7.2% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $48,092,000 $12,677,000 +$1,786,000 +16% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $46,306,000 $12,682,000 +$1,898,000 +18% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $44,408,000 $11,544,000 +$1,083,000 +10% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $43,325,000 $11,189,000 +$1,079,000 +11% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $42,246,000 $10,891,000 -$6,000 -0.06% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $42,252,000 $10,784,000 -$170,000 -1.6% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $42,422,000 $10,461,000 +$1,239,000 +13% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $41,183,000 $10,110,000 +$1,263,000 +14% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $39,920,000 $10,897,000 +$1,708,000 +19% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $38,212,000 $10,954,000 +$1,710,000 +18% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $36,502,000 $9,222,000 +$1,439,000 +18% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $35,063,000 $8,847,000 +$1,413,000 +19% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $33,650,000 $9,189,000 +$1,004,000 +12% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $32,646,000 $9,244,000 +$1,136,000 +14% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 $31,510,000 $7,783,000 +$736,000 +10% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $30,774,000 $7,434,000 -$951,000 -11% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $31,725,000 $8,185,000 -$8,000 -0.1% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $31,733,000 $8,108,000 -$555,000 -6.4% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $32,288,000 $7,047,000 -$298,000 -4.1% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $32,586,000 $8,385,000 +$985,000 +13% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $31,601,000 $8,193,000 +$461,000 +6% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
Q3 2017 $31,140,000 $8,663,000 +$1,302,000 +18% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $29,838,000 $7,345,000 -$320,000 -4.2% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $30,158,000 $7,400,000 -$1,090,000 -13% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q4 2016 $31,248,000 $7,732,000 -$1,997,000 -21% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $33,245,000 $7,361,000 -$1,465,000 -17% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $34,710,000 $7,665,000 +$369,000 +5.1% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $34,341,000 $8,490,000 +$973,000 +13% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $33,368,000 $9,729,000 -$15,093,000 -61% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $48,461,000 $8,826,000 +$1,140,000 +15% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 $47,321,000 $7,296,000 +$1,759,000 +32% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $45,562,000 $7,517,000 +$3,542,000 +89% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q4 2014 $42,020,000 $24,822,000 +$21,536,000 +655% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $20,484,000 $7,686,000 +$3,909,000 +103% 01 Jul 2014 30 Sep 2014 10-Q 27 Oct 2015 2015 Q3
Q2 2014 $16,575,000 $5,537,000 +$3,312,000 +149% 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2015 Q2
Q1 2014 $13,263,000 $3,975,000 +$1,750,000 +79% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q4 2013 $11,513,000 $3,286,000 +$1,731,000 +111% 01 Oct 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
Q3 2013 $9,782,000 $3,777,000 +$2,308,000 +157% 01 Jul 2013 30 Sep 2013 10-Q 30 Oct 2014 2014 Q3
Q2 2013 $7,474,000 $2,225,000 +$1,185,000 +114% 01 Apr 2013 30 Jun 2013 10-Q 31 Jul 2014 2014 Q2
Q1 2013 $6,289,000 $2,225,000 +$1,513,000 +212% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q4 2012 $4,776,000 $1,555,000 01 Oct 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
Q3 2012 $1,469,000 +$1,027,000 +232% 01 Jul 2012 30 Sep 2012 10-Q 31 Oct 2013 2013 Q3
Q2 2012 $1,040,000 +$489,000 +89% 01 Apr 2012 30 Jun 2012 10-Q 06 Aug 2013 2013 Q2
Q1 2012 $712,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q3 2011 $442,000 01 Jul 2011 30 Sep 2011 10-Q 01 Nov 2012 2012 Q3
Q2 2011 $551,000 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2

Pacira BioSciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $57,502,000 +$6,331,000 +12% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $51,171,000 +$3,276,000 +6.8% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $47,895,000 -$197,000 -0.41% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $48,092,000 +$5,846,000 +14% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $42,246,000 +$2,326,000 +5.8% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $39,920,000 +$6,270,000 +19% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $33,650,000 +$1,925,000 +6.1% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $31,725,000 +$124,000 +0.39% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $31,601,000 +$353,000 +1.1% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $31,248,000 -$2,120,000 -6.4% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $33,368,000 +$8,546,000 +34% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $24,822,000 +$13,309,000 +116% 01 Jan 2014 31 Dec 2014 10-K 25 Feb 2016 2015 FY
2013 $11,513,000 +$6,737,000 +141% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $4,776,000 +$2,283,000 +92% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $2,493,000 +$2,470,000 +10739% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $23,000 01 Jan 2010 31 Dec 2010 10-K 07 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.